Industry News
Pharmaceutical Industry News
Catalent snaps up NJ cell therapy plant for $44.5M days after revealing big biologics expansion
Catalent snaps up NJ cell therapy plant for $44.5M days after revealing big biologics expansion fkansteiner Mon, 04/25/2022 - 09:12
Pfizer’s blood pressure med recall creeps into US as testing flags carcinogen threat
Pfizer's blood pressure med recall creeps into US as testing flags carcinogen threat fkansteiner Mon, 04/25/2022 - 07:58
Roche posted a big Q1 sales gain. So why is the company expecting a slowdown later this year?
Roche posted a big Q1 sales gain. So why is the company expecting a slowdown later this year? aliu Mon, 04/25/2022 - 06:19
Gilead touts analysis showing COVID antiviral Veklury performs best when given early in illness
Gilead touts analysis showing COVID antiviral Veklury performs best when given early in illness kdunleavy Sun, 04/24/2022 - 13:49
Boss Trump, ‘the Sorest Loser of All Time’
Readers reflect on Donald Trump as both a party boss and a sore loser. Also: Reforming the patent system.
The Perils of Legalization
We answer a common reader question about the opioid crisis and legalizing drugs.
Masks … Off?
And information about antivirals, from Times reporters and readers.
Covid Drugs Save Lives, but Americans Can’t Get Them
Once again, a dysfunctional health care system has hindered our pandemic response.
IBSA enlists PGA golfer James Hahn as spokesman for Licart pain patch
IBSA enlists PGA golfer James Hahn as spokesman for Licart pain patch nmissakian Fri, 04/22/2022 - 13:56
After Brexafemme approval, Scynexis touts data that could broaden the antifungal’s reach
After Brexafemme approval, Scynexis touts data that could broaden the antifungal's reach kdunleavy Fri, 04/22/2022 - 11:12
With 200M unused doses, AstraZeneca’s COVID vaccine partner Serum Institute halts production
With 200M unused doses, AstraZeneca's COVID vaccine partner Serum Institute halts production aliu Fri, 04/22/2022 - 10:55
As US launch falters, Biogen ditches Aduhelm application in Europe
As US launch falters, Biogen ditches Aduhelm application in Europe fkansteiner Fri, 04/22/2022 - 10:50
After manufacturing hiccup, Revance set for September FDA decision on Botox rival
After manufacturing hiccup, Revance set for September FDA decision on Botox rival zbecker Fri, 04/22/2022 - 10:05
WHO gives a thumbs up to Pfizer’s Paxlovid while scolding the company for its ‘lack of price transparency’
WHO gives a thumbs up to Pfizer's Paxlovid while scolding the company for its 'lack of price transparency' kdunleavy Fri, 04/22/2022 - 09:43
Regeneron CEO’s pay drops 95%—but that shouldn’t come as a shock
Regeneron CEO's pay drops 95%—but that shouldn't come as a shock fkansteiner Fri, 04/22/2022 - 08:27
Fierce Pharma Asia—Merck’s Romanelli returns; Sanofi’s ‘factory of the future’; Fujifilm’s $450M contract
Fierce Pharma Asia—Merck's Romanelli returns; Sanofi's 'factory of the future'; Fujifilm's $450M contract aliu Fri, 04/22/2022 - 07:54
Global trust in pharma CEOs in the doldrums when it comes to ‘telling the truth about health’
Global trust in pharma CEOs in the doldrums when it comes to 'telling the truth about health' badams Fri, 04/22/2022 - 07:49
With millions on the line, Alkermes, J&J start arbitration over drug delivery tech dispute
With millions on the line, Alkermes, J&J start arbitration over drug delivery tech dispute ntaylor Fri, 04/22/2022 - 05:58
Consegna buys Fathom to expand long-acting injectable pipeline
Consegna buys Fathom to expand long-acting injectable pipeline ntaylor Fri, 04/22/2022 - 05:55
BioMarin joins pharma’s filmmaking push with hemophilia documentary project
BioMarin joins pharma's filmmaking push with hemophilia documentary project badams Fri, 04/22/2022 - 05:43